Abstract
SIOG2021-0035 - A phase I dose expansion study of NBTXR3, radiation enhancing hafnium oxide nanoparticles, for the treatment of cisplatin-ineligible locally advanced HNSCC patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have